MLN9708 |CAS:1239908-20-3 Probechem Biochemicals

Chemical Structure : MLN9708

CAS No.: 1239908-20-3

加入收藏

MLN9708 (Ixazomib citrate;MLN 9708;MLN-9708)

货号: PC-42595Not For Human Use, Lab Use Only.

Ixazomib citrate (MLN9708) is a potent, selective, orally bioavailable proteasome inhibitor with IC50 of 3.4 nM.

规格	价格	库存
50 mg	￥1280	In stock
100 mg	￥1980	In stock
200 mg		Get quote
1 g		Get quote

获取报价单

* 请选择数量再加入购物车

or Bulk Inquiry

大包装，大折扣！

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

生物&药学活性

Ixazomib citrate (MLN9708) is a potent, selective, orally bioavailable proteasome inhibitor with IC50 of 3.4 nM.
Ixazomib citrate (MLN9708) binds to and inhibits the chymotrypsin-like proteolytic (β5) site of the 20S proteasome with Ki of 0.93 nM, weakly inhibits the caspase-like (β1) and trypsin-like (β2) proteolytic sites (IC50 of 31 and 3,500 n M).
Ixazomib citrate (MLN9708) inhibits growth and induces apoptosis in MM cells.
Ixazomib citrate (MLN9708) shows improved antitumor activity in models of lymphoma compared with bortezomib.

物理化学性质&存储条件

分子量	517.1216
分子式	C20H23BCl2N2O9
外观性状	Solid
CAS No.
储存条件	固体粉末 -20 °C 12 个月; 4°C 6 个月	配置液 -80 °C 6 个月; -20°C 6 个月
Shipping
Solubility	10 mM in DMSO
Chemical Name/SMILES	1,3,2-Dioxaborolane-4,4-diacetic acid, 2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-

参考文献

1. Kupperman E, et al. Cancer Res. 2010 Mar 1;70(5):1970-80.

2. Chauhan D, et al. Clin Cancer Res. 2011 Aug 15;17(16):5311-21.

3. Lee EC, et al. Clin Cancer Res. 2011 Dec 1;17(23):7313-23.

4. Tian Z, et al. Blood. 2012 Nov 8;120(19):3958-67.

MLN9708 (Ixazomib citrate;MLN 9708;MLN-9708)

生物&药学活性

物理化学性质&存储条件

参考文献

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

询单

MLN9708 (Ixazomib citrate;MLN 9708;MLN-9708)

生物&药学活性

物理化学性质&存储条件

参考文献

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

询单

Get Quotation Now

* Indicates a Required FieldYour information is safe with us.